Thu, Nov 12, 2026 - Page 15
13819 indexed SquawkNews stories from this UTC day. Showing 1681-1800.
L
Shimmick Swings to Q3 2026 Net Income of $848,000 From Year-Earlier Loss
Shimmick Swings to Q3 2026 Net Income of $848,000 From Year-Earlier Loss Shimmick swung to third
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Sensus Healthcare Q3 revenue falls on product mix shift, misses estimates
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
Sensus Healthcare Q3 revenue falls on product mix shift, misses estimates
Sensus Healthcare Q3 revenue falls on product mix shift, misses estimates Overview US medical device
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
Akari Therapeutics Q3 2026 net loss narrows 25% to $4.8 million
Akari Therapeutics Q3 2026 net loss narrows 25% to $4.8 million Akari Therapeutics’ third-quarte
EQUITY | Nov 12, 2026, 09:22 PM UTC
H
Arrowhead Research: Fiscal Q4 Earnings Snapshot
PASADENA, Calif. (AP) — PASADENA, Calif.
EARNINGS | Nov 12, 2026, 09:22 PM UTC
H
Vuzix: Q3 Earnings Snapshot
WEST HENRIETTA, N.Y. (AP) — WEST HENRIETTA, N.Y.
EARNINGS | Nov 12, 2026, 09:22 PM UTC
H
LifeMD beats by $0.03, misses on revs; Issues downside Q4 revenue guidance
Reports Q3 EPS of ($0.11), $0.03 better than the ($0.14) FactSet Consensus estimate; Revenue decreas
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
OpenWorld swings to Q3 net loss of $10.2 million; Q3 revenue drops 64% to $7.43 million
OpenWorld swings to Q3 net loss of $10.2 million; Q3 revenue drops 64% to $7.43 million OpenWorl
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
AmpliTech Q3 2026 net loss narrows 39% from Q2 to $1.89 million; Q3 2026 revenue rises 8% year-over-year to $6.58 million
AmpliTech Q3 2026 net loss narrows 39% from Q2 to $1.89 million; Q3 2026 revenue rises 8% year-over
EARNINGS | Nov 12, 2026, 09:22 PM UTC
H
HawkEye 360: Q3 Earnings Snapshot
HERNDON, Va. (AP) — HERNDON, Va.
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
Verrica Pharmaceuticals Inc. (VRCA) Reports $5.7M YCANTH Revenue, Up 57.9% Year Over Year
Verrica reported Q3 2026 U.S. YCANTH net product revenue of $5.7M, up 11.9% from the prior quarter and 57.9% year over year, and total revenue of $6.9M. It unlocked access to $27.5M in growth capital and expects cash to
EARNINGS | Nov 12, 2026, 09:22 PM UTC
H
York Space Systems Inc. (YSS) Q3 Revenue Falls 7%; FY2026 Guidance Narrowed
Q3 revenue was $84.2M, down 7% year over year; gross margin fell 400 bps to 18%. York recorded a $749.7M non-cash goodwill impairment and narrowed FY2026 revenue guidance to $380M—$400M.Material DetailsContext by AI Anal
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
Xos, Inc. (XOS) Reports Third Straight Quarter of Positive GAAP Gross Profit
Xos reported its third consecutive quarter of positive GAAP gross profit. Nine-month GAAP gross margin rose to 26.9% from 13.3% a year earlier; the company revised its 2026 outlook due to results to date and changed four
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
Serina Therapeutics (SER) Advances SER-252 to Cohort 2; Q3 Net Loss $7.9M
Serina reported a Q3 2026 net loss of $7.9M, or $0.31 per share, versus $4.7M, or $0.45 per share, in Q3 2025. The safety committee recommended advancing SER-252, and Cohort 2 dosing has begun; topline single-ascending-d
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Independent Safety Monitoring Committee recommended advancement of SER-252 in Parkinson's disease to Cohort 2— Dosing initiated in Cohort 2 of the registrational study; topline single-ascending-dose data expected in the
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Obsidian Therapeutics Reports $50.7 Million Q3 Net Loss, $324.4 Million in Cash
Obsidian Therapeutics reported a third-quarter 2026 net loss of $50.7 million, or $1.23 per share, and $324.4 million in cash, cash equivalents and marketable securities at September 30. The company said its cash is expe
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results
Company reports record U.S. YCANTH net product revenue of $5.7 million in Q3 2026, up 11.9% over the previous quarter and 57.9% year-over-year, and total revenue of $6.9 million —— Enrollment completed in the first of tw
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
XOS Q3 EPS USD -0.52
XOS Q3 EPS USD -0.52
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
dLocal Q3 2026 Net Income Rises 31% Year-on-Year to USD 68 Million; Q3 2026 Revenue Climbs 41% to USD 398 Million Year-on-Year
dLocal Q3 2026 Net Income Rises 31% Year-on-Year to USD 68 Million; Q3 2026 Revenue Climbs 41% to US
EARNINGS | Nov 12, 2026, 09:22 PM UTC
H
*-- Earnings Flash (ZEFI, ZEFI.NE) Zefiro Methane Corp. Reports Q1 Revenue $12.1M
*-- Earnings Flash (ZEFI, ZEFI.NE) Zefiro Methane Corp. Reports Q1 Revenue $12.1M
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
Birchcliff Energy 3Q EPS C$0.04 >BIR.T
Birchcliff Energy 3Q EPS C$0.04 >BIR.T
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
SUNNYVALE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported fi
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Digimarc Q3 revenue falls on contract expirations
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
MediaAlpha to Cancel and Retire Repurchased Shares
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Boeing Executive Sells 2,994 Shares for $523,665
Raymond David Christopher sold 2,994 Boeing shares at $174.905 each. After the sale, he directly owned 38,456 shares and indirectly owned 9,881 shares.
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Energous Q3 revenue jumps 167% as shipments rise
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
York Space Systems Reports Third Quarter 2026 Results
York Space Systems Inc. (NYSE:YSS) (York) today announced financial results for the quarter ended September 30, 2026.York also announced today that Brian Frantz has been appointed as permanent Chief Financial Officer of
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Digimarc Q3 revenue falls on contract expirations
Digimarc Q3 revenue falls on contract expirations Overview Digital watermarking firm's Q3 revenue fe
EARNINGS | Nov 12, 2026, 09:22 PM UTC
H
MacroGenics Q3 Revenue Falls to $18.7M; Net Loss $20.1M
MacroGenics reported third-quarter 2026 revenue of $18.7 million, down from $53.0 million a year earlier, and a net loss of $20.1 million. Cash, cash equivalents and marketable securities totaled $287.7 million at Septem
EARNINGS | Nov 12, 2026, 09:22 PM UTC
M
Applied Optoelectronics Completes $102.25 Million Houston Campus Acquisition
Applied Optoelectronics acquired three buildings at Houston’s Hightower Business Park, totaling approximately 736,216 rentable square feet for manufacturing, warehouse and office use.
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
York Space Systems Reports Third Quarter 2026 Results
Identified Pipeline Expands 30%, as Anticipated Focus on Competition and Vendor Diversity Strengthen
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Ascend Wellness Holdings Q3 Revenue Rises 4.2% to $130 Million
Ascend Wellness Holdings reported third-quarter 2026 net revenue of $130.0 million, up 4.2% year over year, and Adjusted EBITDA of $31.1 million. The company recorded a net loss of $28.0 million and generated $5.4 millio
EARNINGS | Nov 12, 2026, 09:22 PM UTC
M
Heartflow Reports Q3 2026 Results, Raises Full-Year Guidance
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Azora Therapeutics Reports $64.6 Million Q3 Net Loss and $22.0 Million in Cash
Azora Therapeutics reported a third-quarter 2026 net loss of $64.6 million, including a $57.1 million noncash charge related to milestone warrant rights. Cash and cash equivalents totaled $22.0 million at September 30, 2
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Knightscope Q3 revenue jumps
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:22 PM UTC
M
Shimmick Swings to $1M Q3 Net Income, Narrows EBITDA Guidance
Shimmick reported Q3 2026 net income of $1 million, compared with a $4 million loss a year earlier, and diluted EPS of $0.02 versus a $0.12 loss. It narrowed fiscal 2026 adjusted EBITDA guidance to $20 million–$25 millio
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
MultiSensor AI Holdings, Inc. (MSAI) Reports Q3 2026 Results; Figures Not Included
MultiSensor AI Holdings, Inc. announced financial results for the quarter ended September 30, 2026. The release says software subscriptions were the majority of quarterly revenue, recurring revenue continued to grow, and
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
Energous Q3 revenue jumps 167% as shipments rise
Energous Q3 revenue jumps 167% as shipments rise Overview US wireless power solutions provider's Q3
EARNINGS | Nov 12, 2026, 09:22 PM UTC
L
YORK SPACE SYSTEMS REPORTS THIRD QUARTER 2026 RESULTS
YORK SPACE SYSTEMS REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:22 PM UTC
L
Bolt Biotherapeutics Names Sheila Gujrathi Chief Strategy Officer
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
Knightscope Q3 revenue jumps
Knightscope Q3 revenue jumps Overview Security technology firm's Q3 revenue rose 177% yr/yr to $8.7
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
SKYX Platforms Q3 revenue rises 7.4% but misses estimates
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
TMC The Metals Company Q3 Loss Narrows
04:21 PM EST, 11/12/2026 (MT Newswires) -- TMC The Metals Company (TMC) reported a Q3 loss late Thur
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
SKYX Platforms Q3 revenue rises 7.4% but misses estimates
SKYX Platforms Q3 revenue rises 7.4% but misses estimates Overview US smart home tech firm's Q3 reve
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
Relmada Therapeutics Q3 net loss widens on higher R&D costs
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
Relmada Therapeutics Q3 net loss widens on higher R&D costs
Relmada Therapeutics Q3 net loss widens on higher R&D costs Overview US biotech reported Q3 net loss
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
MultiSensor AI Announces Third Quarter 2026 Results
Alpharetta, Georgia--(. - November 12, 2026) - MultiSensor AI Holdings, Inc. NASDAQ:MSAI (the "Company", "MultiSensor AI" or "MSAI") today announced financial results for the third quarter ended September 30, 2026.Asim A
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
Chevron Vice Chairman Sold 112,000 Shares
Nelson Mark A sold 112,000 Chevron shares on November 10, 2026, in two transactions at weighted-average prices of $210.4734 and $210.4828 per share. He held 11,647 shares directly afterward.
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
Trisul Net Debt Falls 33.2% Year Over Year to R$ 319.84 Million in Q3
Trisul Net Debt Falls 33.2% Year Over Year to R$ 319.84 Million in Q3 Trisul's net debt fell 28.
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
KINDERCARE LEARNING COMPANIES INC OUTLOOK FY ADJUSTED EPS USD 0.02-0.04
KINDERCARE LEARNING COMPANIES INC OUTLOOK FY ADJUSTED EPS USD 0.02-0.04
EARNINGS | Nov 12, 2026, 09:21 PM UTC
H
Flowers Foods: Q3 Earnings Snapshot
THOMASVILLE, Ga. (AP) — THOMASVILLE, Ga.
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
Ascend Wellness Holdings Reports Wider Loss, Higher Revenue for Third Quarter
04:21 PM EST, 11/12/2026 (MT Newswires) -- Ascend Wellness Holdings (AAWH-U.CN) after trade Thursday
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
ResMed Files Beneficial Ownership Change Statement
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
BRIEF-Xos Q3 Revenue USD 5.5 Million
Nov 12 (Reuters) - Xos Q3 income from operations USD -7.5 million.
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
BIOSTEM TECHNOLOGIES OUTLOOK FY REV $28 MLN TO $29 MLN
BIOSTEM TECHNOLOGIES OUTLOOK FY REV $28 MLN TO $29 MLN
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
Equillium posts narrower-than-expected Q3 net loss; expects cash runway to fund operations into 2029
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:21 PM UTC
L
Park Dental Partners Q3 revenue rises, helped by acquisitions
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
BRIEF-Xos Q3 Revenue USD 5.5 Million
BRIEF-Xos Q3 Revenue USD 5.5 Million Nov 12 (Reuters) - Xos Q3 income from operations USD -7.5 milli
EARNINGS | Nov 12, 2026, 09:21 PM UTC
L
Park Dental Partners Q3 revenue rises, helped by acquisitions
Park Dental Partners Q3 revenue rises, helped by acquisitions Overview US dental resource firm's Q3
EARNINGS | Nov 12, 2026, 09:21 PM UTC
H
Jefferson Capital Q3 Revenue Rises
04:20 PM EST, 11/12/2026 (MT Newswires) -- Jefferson Capital (JCAP) reported Q3 adjusted earnings la
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Equillium posts narrower-than-expected Q3 net loss; expects cash runway to fund operations into 2029
Equillium posts narrower-than-expected Q3 net loss; expects cash runway to fund operations into 2029
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
Streamex Q3 net loss widens on higher expenses
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
United States Antimony Q3 revenue misses estimates
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
EPAM Officer Sells 3,299 Shares Worth $528,301
SVP and Chief People Officer Solomon Lawrence F sold 3,299 shares at $160.14 each. He directly owns 30,390 shares following the transaction.
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
Streamex Q3 net loss widens on higher expenses
Streamex Q3 net loss widens on higher expenses Overview U.S. commodity tokenization firm's Q3 net lo
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
QXO INC Q3 ADJ EPS $0.13
QXO INC Q3 ADJ EPS $0.13
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
United States Antimony Q3 revenue misses estimates
United States Antimony Q3 revenue misses estimates Overview U.S. antimony and zeolite producer's Q3
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Solésence Q3 swings to net income of $3.7 million; revenue rises 38% to $20.2 million
Solésence Q3 swings to net income of $3.7 million; revenue rises 38% to $20.2 million Solésence
CRYPTO | Nov 12, 2026, 09:20 PM UTC
L
Staffing franchisor HireQuest's Q3 net income falls on write down impact
Staffing franchisor HireQuest's Q3 net income falls on write down impact Overview U.S. staffing fran
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
WidePoint Q3 revenue rises on federal contract awards
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Staffing franchisor HireQuest's Q3 net income falls on write down impact
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:20 PM UTC
M
System1 Q3 Revenue Falls
System1 reported lower third-quarter revenue, citing an impact from Google.
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
WidePoint Q3 revenue rises on federal contract awards
WidePoint Q3 revenue rises on federal contract awards Overview Secure mobility management firm's Q3
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Virgin Galactic Sees 4Q Free Cash Flow in the Range of -$80M to -$90M >SPCE
Virgin Galactic Sees 4Q Free Cash Flow in the Range of -$80M to -$90M >SPCE
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
Cibus Reports Q3 2026 Results; Operating Cash Use Falls 19%
Cibus reported third-quarter 2026 revenue of $800,000 and a net loss of $21.9 million, compared with revenue of $615,000 and a net loss of $24.3 million a year earlier. Net cash used in operating activities fell about 19
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Inuvo Q3 revenue falls 70%, misses analyst estimates
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
QXO, INC Q3 EPS USD -0.17
QXO, INC Q3 EPS USD -0.17
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Inuvo Q3 revenue falls 70%, misses analyst estimates
Inuvo Q3 revenue falls 70%, misses analyst estimates Overview AI audience modeling firm's Q3 revenue
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Boeing Executive Reports Sale of $523,665.57 in Common Shares
Boeing EVP and BGS President and CEO David Christopher Raymond reported a sale of $523,665.57 in common shares.
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
RMR GROUP Q4 REVENUE USD 163.7 MILLION
RMR GROUP Q4 REVENUE USD 163.7 MILLION
EARNINGS | Nov 12, 2026, 09:20 PM UTC
H
Lineage Cell: Q3 Earnings Snapshot
CARLSBAD, Calif. (AP) — CARLSBAD, Calif.
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
NorthStar Earth & Space Q3 Swings to Income, Revenue Rises
04:20 PM EST, 11/12/2026 (MT Newswires) -- NorthStar Earth & Space (NSTR) reported Q3 net income lat
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
US Treasury Yields Extend Rise, 5-Year Yield Up 15bps On The Day
US Treasury Yields Extend Rise, 5-Year Yield Up 15bps On The Day
NEWS | Nov 12, 2026, 09:20 PM UTC
L
Merlin swings to Q3 2026 net income of $73.84 million from Q2 loss
Merlin swings to Q3 2026 net income of $73.84 million from Q2 loss Merlin swung to third-quarter
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Independent Safety Monitoring Committee recommended advancement of SER-252 in Parkinson's disease
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
XOS Q3 REVENUE USD 5.5 MILLION
XOS Q3 REVENUE USD 5.5 MILLION
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
XOS Q3 PRETAX PROFIT USD -7.605 MILLION
XOS Q3 PRETAX PROFIT USD -7.605 MILLION
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
XOS Q3 NET INCOME USD -7.6 MILLION
XOS Q3 NET INCOME USD -7.6 MILLION
FX | Nov 12, 2026, 09:20 PM UTC
L
Fractyl Health Reports Q3 2026 Net Loss of $14.2 Million and Positive Revita Trial Results
Fractyl Health reported a third-quarter 2026 net loss of $14.2 million, compared with $45.6 million a year earlier, while operating expenses declined to $18.6 million. The company said its REMAIN-1 pivotal cohort met its
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
XOS Q3 INCOME FROM OPERATIONS USD -7.5 MILLION
XOS Q3 INCOME FROM OPERATIONS USD -7.5 MILLION
FX | Nov 12, 2026, 09:20 PM UTC
L
Rekor Systems Q3 Revenue Falls 23% as Recurring Revenue Grows 16%
Rekor Systems reported third-quarter 2026 revenue of $10.9 million, down 23% year over year, while recurring revenue rose 16% to $7.5 million. Net loss narrowed to $2.9 million from $4.1 million a year earlier. For the f
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
SERINA THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
SERINA THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
Sensus Healthcare Reports $6.0 Million Revenue and 55% Gross Margin in Q3 2026
Sensus Healthcare reported third-quarter 2026 revenue of $6.0 million, down 13% year over year, while gross margin increased to 55% from 39.1%. The company recorded a net loss of $1.5 million, or $0.09 per diluted share,
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
XOS Q3 ADJUSTED OPERATING INCOME USD -4.1 MILLION
XOS Q3 ADJUSTED OPERATING INCOME USD -4.1 MILLION
FX | Nov 12, 2026, 09:20 PM UTC
L
Snail Reports Q3 2026 Revenue of $33.1 Million and Net Income of $6.7 Million
Snail reported third-quarter 2026 revenue of $33.1 million, up 139.2% year over year, and net income of $6.7 million compared with a loss a year earlier. Gross profit was $17.6 million, and operating income was $7.2 mill
EARNINGS | Nov 12, 2026, 09:20 PM UTC
L
Exyn CFO Ricardo Sotelo Resigns; Benjamin Williams Takes Finance Role
Exyn said Interim CEO Benjamin Williams was designated principal financial and accounting officer.
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates — In
EQUITY | Nov 12, 2026, 09:20 PM UTC
L
Lifeway Foods Reports Record $67.8 Million Quarterly Sales as Profit Declines
Lifeway Foods reported record third-quarter net sales of $67.8 million, up 18.6% year over year, as higher volumes of branded drinkable kefir drove growth. Gross margin fell to 18.0% amid elevated input costs, and net in
EARNINGS | Nov 12, 2026, 09:20 PM UTC
M
Lineage Announces Acquisition of NeuroAirmid Therapeutics
The acquisition includes a clinical-stage program for the treatment of Huntington's disease.
MNA | Nov 12, 2026, 09:20 PM UTC
M
STERIS Prices $1.5 Billion in Senior Notes to Fund Pending Acquisition
STERIS priced $1.5 billion in senior notes, with proceeds intended in part to fund its pending acquisition of Xodus Medical.
MNA | Nov 12, 2026, 09:19 PM UTC
L
Trump: Might Not Negotiate With Democrats During Impeachment, Responding To Hypothetical Question
Trump: Might Not Negotiate With Democrats During Impeachment, Responding To Hypothetical Question
NEWS | Nov 12, 2026, 09:19 PM UTC
H
AFYA LIMITED: FULL-YEAR 2026 GUIDANCE REAFFIRMED
AFYA LIMITED: FULL-YEAR 2026 GUIDANCE REAFFIRMED
EARNINGS | Nov 12, 2026, 09:19 PM UTC
H
Applied Materials Q4 26 Earnings
Net Sales: $10.41B (est $10.27B) Adj EPS: $4.16 (est $4.06) Semiconductor Systems Net Sales: $8.00B (est $7.94B) Sees Q1 Net Sales: $10.60B To $11.60B (est $10.87B)
EARNINGS | Nov 12, 2026, 09:19 PM UTC
L
Virgin Galactic 3Q Rev $427,000 >SPCE
Virgin Galactic 3Q Rev $427,000 >SPCE
EQUITY | Nov 12, 2026, 09:19 PM UTC
L
TMC the Metals Company 3Q Loss/Shr 6c >TMC
TMC the Metals Company 3Q Loss/Shr 6c >TMC
EQUITY | Nov 12, 2026, 09:19 PM UTC
L
Viatris Files Amended Tender Offer Statement for Pacira BioSciences
Viatris filed an amended Schedule TO tender offer statement concerning Pacira BioSciences. The filing date is listed as November 12, but the year is truncated.
MNA | Nov 12, 2026, 09:19 PM UTC
L
RMR GROUP Q4 ADJUSTED NET INCOME USD 3.7 MILLION
RMR GROUP Q4 ADJUSTED NET INCOME USD 3.7 MILLION
FX | Nov 12, 2026, 09:19 PM UTC
L
Birchcliff Energy Swings to a Third-Quarter Profit
04:19 PM EST, 11/12/2026 (MT Newswires) -- Birchcliff Energy (BIR.TO) reported a swing to a third-qu
EARNINGS | Nov 12, 2026, 09:19 PM UTC
H
*-- Earnings Flash (LFTO) Liftoff Mobile Posts Q3 EPS $0.47, vs. FactSet Est of $0.18
*-- Earnings Flash (LFTO) Liftoff Mobile Posts Q3 EPS $0.47, vs. FactSet Est of $0.18
EARNINGS | Nov 12, 2026, 09:19 PM UTC
H
*-- GUIDANCE: (HAWK) HawkEye 360 Expects 2026 Revenue Range $225M - $227M, vs. FactSet Est of $217.2M
*-- GUIDANCE: (HAWK) HawkEye 360 Expects 2026 Revenue Range $225M - $227M, vs. FactSet Est of $217.2M
EARNINGS | Nov 12, 2026, 09:19 PM UTC
L
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
SUNNYVALE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc.
EQUITY | Nov 12, 2026, 09:19 PM UTC
L
S&P/TSX Composite Closes Nearly 275 Points Lower
The S&P/TSX Composite Index closed lower Thursday, with base metals and healthcare stocks weighing.
EQUITY | Nov 12, 2026, 09:19 PM UTC
M
Cerebras Reports Third-Quarter Loss of $161.2 Million
EQUITY | Nov 12, 2026, 09:19 PM UTC
L
Alnylam Director Amy W. Schulman Bought $299,526 in Shares
A recent SEC filing says Amy W. Schulman, a director, executed the share purchase on November 9, 2026.
EQUITY | Nov 12, 2026, 09:19 PM UTC
L
FLUENT INC: REMAIN CONFIDENT IN DELIVERING FY DOUBLE-DIGIT REVENUE GROWTH ON AGGREGATE CONTINUING BUSINESSES WITH IMPROVED FY ADJUSTED EBITD
FLUENT INC: REMAIN CONFIDENT IN DELIVERING FY DOUBLE-DIGIT REVENUE GROWTH ON AGGREGATE CONTINUING BU
EARNINGS | Nov 12, 2026, 09:19 PM UTC
M
HeartFlow Q3 Adjusted Loss Narrows as Revenue Rises; 2026 Guidance Raised
HeartFlow reported a narrower adjusted loss and higher revenue for Q3 and raised its 2026 revenue guidance.
EQUITY | Nov 12, 2026, 09:19 PM UTC
L
BIOCARDIA REPORTS THIRD QUARTER 2026 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS
BIOCARDIA REPORTS THIRD QUARTER 2026 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:19 PM UTC
L
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results SUNNYVALE, Calif., No
EQUITY | Nov 12, 2026, 09:19 PM UTC
H
*--Earnings Flash (HAWK) HawkEye 360 Posts Q3 Breakeven, vs. FactSet Est of $0.05 Loss Per Share
*--Earnings Flash (HAWK) HawkEye 360 Posts Q3 Breakeven, vs. FactSet Est of $0.05 Loss Per Share
EARNINGS | Nov 12, 2026, 09:19 PM UTC
H
*-- Earnings Flash (ANAB) AnaptysBio, Inc. Reports Q1 Revenue $30.3M, vs. FactSet Est of $18.9M
*-- Earnings Flash (ANAB) AnaptysBio, Inc. Reports Q1 Revenue $30.3M, vs.
EARNINGS | Nov 12, 2026, 09:19 PM UTC